Effect of estradiol treatment on beta-endorphin content and release in the female rat hypothalamus.
The purpose of the present study was to determine whether an injection of estradiol valerate or chronic estradiol treatment alters beta-endorphin-immunoreactive (IR) material in the hypothalamus. Hypothalamic beta-endorphin-IR material was significantly reduced (by 47%) 2 months following an estradiol valerate injection. In addition, both the basal and veratridine-evoked release of beta-endorphin-IR material from hypothalamic slices incubated in vitro were decreased 48% and 52%, respectively. The net release of beta-endorphin-IR material was decreased by 50% compared to control animals. Chronic estradiol treatment (2 months) did not alter the tissue content of beta-endorphin-IR material. Although, we noted a significant decrease (48%) of the basal release and a significant increase (45%) of the evoked release, the net release of beta-endorphin-IR material from slices was not altered (107% of control). The present results suggest that estradiol valerate treatment decreases the capacity of beta-endorphin neurons in the hypothalamus to synthesize and maintain the release of beta-endorphin.